Multi‐model averaging improves the performance of model‐guided infliximab dosing in patients with inflammatory bowel diseases

Abstract Infliximab dosage de‐escalation without prior knowledge of drug concentrations may put patients at risk for underexposure and trigger the loss of response. A single‐model approach for model‐informed precision dosing during infliximab maintenance therapy has proven its clinical benefit in pa...

Descripción completa

Detalles Bibliográficos

Autores principales:	Wannee Kantasiripitak, An Outtier, Sebastian G. Wicha, Alexander Kensert, Zhigang Wang, João Sabino, Séverine Vermeire, Debby Thomas, Marc Ferrante, Erwin Dreesen
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wiley 2022-08-01
Colección:	CPT: Pharmacometrics & Systems Pharmacology
Acceso en línea:	https://doi.org/10.1002/psp4.12813
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!